Copyright Reports & Markets. All rights reserved.

Global Recurrent Glioblastoma Multiforme Treatment Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Recurrent Glioblastoma Multiforme Treatment

      • 1.1 Definition of Recurrent Glioblastoma Multiforme Treatment
      • 1.2 Recurrent Glioblastoma Multiforme Treatment Segment by Type
        • 1.2.1 Global Recurrent Glioblastoma Multiforme Treatment Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 AU-105
        • 1.2.3 Axitinib
        • 1.2.4 AXL-1717
        • 1.2.5 AZD-7451
        • 1.2.6 Others
      • 1.3 Recurrent Glioblastoma Multiforme Treatment Segment by Applications
        • 1.3.1 Global Recurrent Glioblastoma Multiforme Treatment Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Recurrent Glioblastoma Multiforme Treatment Overall Market
        • 1.4.1 Global Recurrent Glioblastoma Multiforme Treatment Revenue (2014-2025)
        • 1.4.2 Global Recurrent Glioblastoma Multiforme Treatment Production (2014-2025)
        • 1.4.3 North America Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2014-2025)
        • 1.4.4 Europe Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2014-2025)
        • 1.4.5 China Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2014-2025)
        • 1.4.6 Japan Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2014-2025)
        • 1.4.8 India Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Recurrent Glioblastoma Multiforme Treatment
      • 2.3 Manufacturing Process Analysis of Recurrent Glioblastoma Multiforme Treatment
      • 2.4 Industry Chain Structure of Recurrent Glioblastoma Multiforme Treatment

      3 Development and Manufacturing Plants Analysis of Recurrent Glioblastoma Multiforme Treatment

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Recurrent Glioblastoma Multiforme Treatment Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Recurrent Glioblastoma Multiforme Treatment
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Recurrent Glioblastoma Multiforme Treatment Production and Capacity Analysis
      • 4.2 Recurrent Glioblastoma Multiforme Treatment Revenue Analysis
      • 4.3 Recurrent Glioblastoma Multiforme Treatment Price Analysis
      • 4.4 Market Concentration Degree

      5 Recurrent Glioblastoma Multiforme Treatment Regional Market Analysis

      • 5.1 Recurrent Glioblastoma Multiforme Treatment Production by Regions
        • 5.1.1 Global Recurrent Glioblastoma Multiforme Treatment Production by Regions
        • 5.1.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue by Regions
      • 5.2 Recurrent Glioblastoma Multiforme Treatment Consumption by Regions
      • 5.3 North America Recurrent Glioblastoma Multiforme Treatment Market Analysis
        • 5.3.1 North America Recurrent Glioblastoma Multiforme Treatment Production
        • 5.3.2 North America Recurrent Glioblastoma Multiforme Treatment Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Recurrent Glioblastoma Multiforme Treatment Import and Export
      • 5.4 Europe Recurrent Glioblastoma Multiforme Treatment Market Analysis
        • 5.4.1 Europe Recurrent Glioblastoma Multiforme Treatment Production
        • 5.4.2 Europe Recurrent Glioblastoma Multiforme Treatment Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Recurrent Glioblastoma Multiforme Treatment Import and Export
      • 5.5 China Recurrent Glioblastoma Multiforme Treatment Market Analysis
        • 5.5.1 China Recurrent Glioblastoma Multiforme Treatment Production
        • 5.5.2 China Recurrent Glioblastoma Multiforme Treatment Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Recurrent Glioblastoma Multiforme Treatment Import and Export
      • 5.6 Japan Recurrent Glioblastoma Multiforme Treatment Market Analysis
        • 5.6.1 Japan Recurrent Glioblastoma Multiforme Treatment Production
        • 5.6.2 Japan Recurrent Glioblastoma Multiforme Treatment Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Recurrent Glioblastoma Multiforme Treatment Import and Export
      • 5.7 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Market Analysis
        • 5.7.1 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Production
        • 5.7.2 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Import and Export
      • 5.8 India Recurrent Glioblastoma Multiforme Treatment Market Analysis
        • 5.8.1 India Recurrent Glioblastoma Multiforme Treatment Production
        • 5.8.2 India Recurrent Glioblastoma Multiforme Treatment Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Recurrent Glioblastoma Multiforme Treatment Import and Export

      6 Recurrent Glioblastoma Multiforme Treatment Segment Market Analysis (by Type)

      • 6.1 Global Recurrent Glioblastoma Multiforme Treatment Production by Type
      • 6.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue by Type
      • 6.3 Recurrent Glioblastoma Multiforme Treatment Price by Type

      7 Recurrent Glioblastoma Multiforme Treatment Segment Market Analysis (by Application)

      • 7.1 Global Recurrent Glioblastoma Multiforme Treatment Consumption by Application
      • 7.2 Global Recurrent Glioblastoma Multiforme Treatment Consumption Market Share by Application (2014-2019)

      8 Recurrent Glioblastoma Multiforme Treatment Major Manufacturers Analysis

      • 8.1 Boehringer Ingelheim GmbH
        • 8.1.1 Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.1.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
        • 8.1.3 Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Boston Biomedical, Inc.
        • 8.2.1 Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.2.2 Boston Biomedical, Inc. Product Introduction, Application and Specification
        • 8.2.3 Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Bristol-Myers Squibb Company
        • 8.3.1 Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.3.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
        • 8.3.3 Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Cantex Pharmaceuticals, Inc.
        • 8.4.1 Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.4.2 Cantex Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.4.3 Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Cavion LLC
        • 8.5.1 Cavion LLC Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.5.2 Cavion LLC Product Introduction, Application and Specification
        • 8.5.3 Cavion LLC Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Celldex Therapeutics, Inc.
        • 8.6.1 Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.6.2 Celldex Therapeutics, Inc. Product Introduction, Application and Specification
        • 8.6.3 Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Coherus BioSciences, Inc.
        • 8.7.1 Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.7.2 Coherus BioSciences, Inc. Product Introduction, Application and Specification
        • 8.7.3 Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Cortice Biosciences, Inc.
        • 8.8.1 Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.8.2 Cortice Biosciences, Inc. Product Introduction, Application and Specification
        • 8.8.3 Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Eisai
        • 8.9.1 Eisai Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.9.2 Eisai Product Introduction, Application and Specification
        • 8.9.3 Eisai Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Eli Lilly and Company
        • 8.10.1 Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
        • 8.10.2 Eli Lilly and Company Product Introduction, Application and Specification
        • 8.10.3 Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 EnGeneIC Ltd
      • 8.12 ERC Belgium SA
      • 8.13 GenSpera, Inc.
      • 8.14 Genzyme Corporation
      • 8.15 GW Pharmaceuticals Plc
      • 8.16 ImmunoCellular Therapeutics, Ltd.

      9 Development Trend of Analysis of Recurrent Glioblastoma Multiforme Treatment Market

      • 9.1 Global Recurrent Glioblastoma Multiforme Treatment Market Trend Analysis
        • 9.1.1 Global Recurrent Glioblastoma Multiforme Treatment Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Recurrent Glioblastoma Multiforme Treatment Regional Market Trend
        • 9.2.1 North America Recurrent Glioblastoma Multiforme Treatment Forecast 2019-2025
        • 9.2.2 Europe Recurrent Glioblastoma Multiforme Treatment Forecast 2019-2025
        • 9.2.3 China Recurrent Glioblastoma Multiforme Treatment Forecast 2019-2025
        • 9.2.4 Japan Recurrent Glioblastoma Multiforme Treatment Forecast 2019-2025
        • 9.2.5 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Forecast 2019-2025
        • 9.2.6 India Recurrent Glioblastoma Multiforme Treatment Forecast 2019-2025
      • 9.3 Recurrent Glioblastoma Multiforme Treatment Market Trend (Product Type)
      • 9.4 Recurrent Glioblastoma Multiforme Treatment Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Recurrent Glioblastoma Multiforme Treatment Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Recurrent Glioblastoma Multiforme Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Recurrent Glioblastoma Multiforme Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recurrent Glioblastoma Multiforme Treatment market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Recurrent Glioblastoma Multiforme Treatment in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Recurrent Glioblastoma Multiforme Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Boehringer Ingelheim GmbH
        Boston Biomedical, Inc.
        Bristol-Myers Squibb Company
        Cantex Pharmaceuticals, Inc.
        Cavion LLC
        Celldex Therapeutics, Inc.
        Coherus BioSciences, Inc.
        Cortice Biosciences, Inc.
        Eisai
        Eli Lilly and Company
        EnGeneIC Ltd
        ERC Belgium SA
        GenSpera, Inc.
        Genzyme Corporation
        GW Pharmaceuticals Plc
        ImmunoCellular Therapeutics, Ltd.

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        AU-105
        Axitinib
        AXL-1717
        AZD-7451
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now